Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments


Benjamin G. Cuiffo1, Ingrid Rankin1, Olivier Deas2, Gregory D. Lyng1, Stephano Cairo2, Enora Le Ven2, Jean-Gabriel Judde2, Stephen T. Sonis1.
1Biomodels, LLC, Watertown, MA, USA; 2XenTech, Evry, France

Poster in collaboration with Biomodels, 2014